Memory DisordersECOTESTGERNCT05668598
Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics
A study testing ecological MAI test in people with Memory Disorders and Neurocognitive Disorders, run by Centre Hospitalier de Lens at 1 site in France.
Trial summary
In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease. Study test is ecological MAI. Read more about this study
- Who is it for?
- Ages 70 years and olderHealthy volunteers can take part
- Conditions the study is for
- Memory Disorders, Neurocognitive Disorders
- What is being tested?
- ecological MAI test
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteFrance
- Study dates
- 8 Mar 2023to 9 Mar 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 70 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- Male or female ≥ 70 ans
- Person have good locomotion, move independently
- Personne agree to participate
- Groupe 1 : 17≤MMSE≤24 (GRECO) Diagnosis of neurodegenerative diseases (major neurocognitive disorders: Alzheimer, mixed dementia, lobar frontotemporal degeneration, vascular dementia).
- Groupe 2 : MMSE ≥ à 25 (GRECO) Without neurodegenerative disease
Who cannot join
- Person with legal protective measures
- Person deprived of liberty
- Mental retardation or MMSE≤ 16
- Understanding verbal disorders
- Visual major disturbances
- Person with disease causing increased fatigue
- Person with psychiatric pathology excepted anxiety disorder or depression with mild episodes.
- Person not covered by French national health insurance
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Centre Hospiralier de Lens
Lens, 62408
MELANIE VERLAY, 0601023068, mverlay@ch-lens.fr
BRUNHILDE CANESSON
About this study
Official title: Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics: an Adaptation of the Memory Test With Self-Initiated Items (MAI)
In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.
Study test is ecological MAI. This test are assigned in two groups (with or without neurocognitive disorders).
Read the detailed description
In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.
Study test is ecological MAI. Participation will be 30 minutes for patients see in case of routine care and 2h30 for those accompanying the patients and participants recruited in external institutions.
Participants are assigned in two groups. Group 1 : with neurocognitive disorders Group 2 : without neurocognitive disorders
Benefits :
For participants without neurodegenerative disorder, study enables to take control early if anomaly will be detected.
The study permit to have cognitive assessment.
Risk : It's possible that participants feel tired. No constraints for participants seen during scheduled consultation.
- Conditions
- Memory Disorders, Neurocognitive Disorders
- Being tested
- ecological MAI test
- Keywords
- GERIATRICS
- Medical subject headings
- Memory Disorders, Neurocognitive Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ecological MAI testDiagnostic test
Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.
Study test is ecological MAI.
| Study group | Role | What they receive |
|---|---|---|
| Groupe 1 : with neurocognitive disorders | Other | with neurocognitive disorders Receives: Diagnostic Test: ecological MAI test |
| Groupe 2 : without neurocognitive disorders | Other | without neurocognitive disorders Receives: Diagnostic Test: ecological MAI test |
What is being measured
The primary outcome is the main question the study is designed to answer.
To compare performance obtaining to overall score remind ecological MAI between older persons with neurocognitive disorders (groupe 1) and older persons without neurocognitive disorders (groupe 2).
Overall score remind ecological MAI test (0 to 12) in two groups.
Measured: day 1
Secondary outcomes (3)
To compare between case and control the various dimensions of episodic memory: temporal component, space component and association component.
Spatial component is defined by localisation score. Score (0 to 12)
Measured: day 1
To compare between case and control the various dimensions of episodic memory: temporal component, space component and association component.
Temporal component is defined by temporal dimension.
Score (0 to 12)
Measured: day 1
To compare between case and control the various dimensions of episodic memory: temporal component, space component and association component.
Association component is defined by binding score.
Score (0 to 12)
Measured: day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Dec 2022
- Study start8 Mar 2023
- Primary completion8 Mar 2028 (estimated)
- Study completion9 Mar 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Memory DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- Interventional, prospective, Study case-control
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Lens
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05668598
- Sponsor's protocol ID
- 2022-02
- Other IDs
- 2022-A02139-34
- Acronym
- ECOTESTGER
- Status last verified
- May 2026
- First submitted
- 9 Dec 2022
- Last updated
- 8 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics: an Adaptation of the Memory Test With Self-Initiated Items (MAI)
- ClinicalTrials.gov ID
- NCT05668598
- Acronym / sponsor ID
- ECOTESTGER / 2022-02
- Conditions
- Memory Disorders, Neurocognitive Disorders
- Keywords
- GERIATRICS
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Centre Hospitalier de LensUniversity, hospital or other
- Study start
- 8 Mar 2023 (actual)
- Primary completion
- 8 Mar 2028 (estimated)
- Study completion
- 9 Mar 2028 (estimated)
- First posted
- 30 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.
Study test is ecological MAI. This test are assigned in two groups (with or without neurocognitive disorders).
Detailed description
In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.
Study test is ecological MAI. Participation will be 30 minutes for patients see in case of routine care and 2h30 for those accompanying the patients and participants recruited in external institutions.
Participants are assigned in two groups. Group 1 : with neurocognitive disorders Group 2 : without neurocognitive disorders
Benefits :
For participants without neurodegenerative disorder, study enables to take control early if anomaly will be detected.
The study permit to have cognitive assessment.
Risk : It's possible that participants feel tired. No constraints for participants seen during scheduled consultation.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Interventional, prospective, Study case-control
| Arm | Type | Receives |
|---|---|---|
| Groupe 1 : with neurocognitive disorders | Other | Diagnostic Test: ecological MAI testwith neurocognitive disorders |
| Groupe 2 : without neurocognitive disorders | Other | Diagnostic Test: ecological MAI testwithout neurocognitive disorders |
Who may qualify
- Ages
- 70 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (5 listed)
- Male or female ≥ 70 ans
- Person have good locomotion, move independently
- Personne agree to participate
- Groupe 1 : 17≤MMSE≤24 (GRECO) Diagnosis of neurodegenerative diseases (major neurocognitive disorders: Alzheimer, mixed dementia, lobar frontotemporal degeneration, vascular dementia).
- Groupe 2 : MMSE ≥ à 25 (GRECO) Without neurodegenerative disease
Key exclusion criteria (8 listed)
- Person with legal protective measures
- Person deprived of liberty
- Mental retardation or MMSE≤ 16
- Understanding verbal disorders
- Visual major disturbances
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ecological MAI testNeuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease. Study test is ecological MAI. | Diagnostic test | Groupe 1 : with neurocognitive disorders, Groupe 2 : without neurocognitive disorders |
Primary outcome
To compare performance obtaining to overall score remind ecological MAI between older persons with neurocognitive disorders (groupe 1) and older persons without neurocognitive disorders (groupe 2).
Time frame: day 1
Overall score remind ecological MAI test (0 to 12) in two groups.
3 secondary outcomes
To compare between case and control the various dimensions of episodic memory: temporal component, space component and association component.
Time frame: day 1
To compare between case and control the various dimensions of episodic memory: temporal component, space component and association component.
Time frame: day 1
To compare between case and control the various dimensions of episodic memory: temporal component, space component and association component.
Time frame: day 1
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2026.
- Individual participant dataSharing planned: No
Related trials for Memory Disorders
Not yet recruitingPhase 3
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol
Post-Traumatic Stress Disorder, PTSD
RecruitingPhase 1
Lm-LLO-TT and Gemcitabine in Unresectable Pancreatic Ductal Adenocarcinoma
Pancreas Cancer, Duct Cell Adenocarcinoma, Pancreatic Cancer
Not yet recruitingObservational study
Prospective Research on Identification of Dementia in Early Stages (P.R.I.D.E)
Mild Cognitive Impairment, Memory Disorders
Active, not recruitingObservational study
A Study of Attention and Memory Processes in Breast Cancer Survivors
Breast Cancer Survivors
Not yet recruiting
A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement
Memory Disorders, Mild Cognitive Impairment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ecological MAI test in people with Memory Disorders and Neurocognitive Disorders, run by Centre Hospitalier de Lens at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Brunhilde CANESSON (03.21.69.16.36 ext. +33, bcanesson@ch-lens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To compare performance obtaining to overall score remind ecological MAI between older persons with neurocognitive disorders (groupe 1) and older persons without neurocognitive disorders (groupe 2). (time frame: day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.